Previous 10 | Next 10 |
FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Company’s Board of Directors effective October 26, 2...
FNCB Bancorp Inc. (FNCB) is expected to report for Q1 2024 Civista Bancshares Inc. (CIVB) is expected to report $0.6 for Q3 2023 ASLAN Pharmaceuticals Limited (ASLN) is expected to report $-0.85 for Q3 2023 Grupo Televisa S.A. (TV) is expected to report $0.02 for Q3 2023 Red River...
2023-10-26 01:18:21 ET Summary Enzo Biochem is a microcap company with a $30 million revenue run-rate Life Sciences business and $78-$85 million in cash. The company is likely being prepared for sale, with interest from potential acquirers and activists controlling 30% of voting s...
South Plains Financial Inc. (SPFI) is expected to report $0.64 for Q3 2023 Grupo Aeroportuario Del Pacifico S.A. B. de C.V. de C.V. (each representing 10 Series B shares) (PAC) is expected to report $3.13 for Q3 2023 Himalaya Technologies Inc (HMLA) is expected to report for Q1 2024 R...
JPMorgan Chase & Co. (JPM) is expected to report $3.89 for Q3 2023 Unity Bancorp Inc. (UNTY) is expected to report $0.89 for Q3 2023 Wells Fargo & Company (WFC) is expected to report $1.25 for Q3 2023 Intellipharmaceutics International Inc (IPCIF) is expected to report for Q1 ...
Enzo Biochem Inc. ($0.01 Par Value) (ENZ) is expected to report for quarter end 2023-07-31
2023-09-06 08:54:38 ET More on Enzo Biochem Financial information for Enzo Biochem For further details see: Enzo Biochem names interim CEO
FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing the Company effective September 5, 2023, with Enzo’s Chief Op...
Significant value unlocked for Enzo shareholders with continued focus on life sciences. FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has closed a transaction to sell certain assets of Enzo’s Clinical laboratory division ...
2023-07-19 07:30:00 ET Summary At Laughing Water Capital, our interests are fully aligned with our partners as nearly all of our personal wealth is invested in our strategy. In the second quarter of 2023, Laughing Water Capital returned approximately 13.8% after all fees and expen...
News, Short Squeeze, Breakout and More Instantly...
Enzo Biochem Inc. Company Name:
ENZ Stock Symbol:
NYSE Market:
Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for...
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024. Second Quarter Highlights The Company's Life Science division's...
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments. Summary of the Fis...